CoreWorks
CoreWorks Raises $75M Series B to Transform Biotech
Quick Facts
CoreWorks Raises $75M Series B in Latest Funding Round
CoreWorks has successfully closed a $75M Series B funding round, marking a significant milestone in the company's growth trajectory. The round was led by 500 Startups, with participation from General Catalyst.
Company Overview
Founded in 2018 and headquartered in Washington, DC, CoreWorks has established itself in the Biotech space. Leading machine learning platform automating enterprise workflows with advanced AI models
With a current valuation of $500M, the company has demonstrated strong market traction and investor confidence.
Investment Details
- Amount Raised: $75M Series B
- Valuation: $500M
- Lead Investor: 500 Startups
Future Outlook
As CoreWorks moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the biotech space.
Key Investors
About the Author

Related Company Reports
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...

StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...

NeuralTech Raises $100M Growth to Transform Biotech
NeuralTech has secured $100M Growth in funding to accelerate growth and innovation. Leading AI-powered analytics platform transforming data into actionable business insights...
